Company / Revenue
NovoCure Ltd Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$655.4M
FY2025
5-year range
$509.3M / $655.4M
FY2021-FY2025
Trend
+8.3%
vs FY2024
Sector context
#110 of 150
Health Care
What the data says
At $655M, NovoCure Ltd's revenue ranks #110 of 150 in the Health Care sector. Improved from $509M to $655M over the past 2 years.
Based on SEC 10-K filings.
$655M in FY2025 with a 5-year CAGR of +5.8%.
Improved from $509M to $655M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +6.8%
- 5-Year CAGR
- +5.8%
- 10-Year CAGR
- -
Sector benchmark
#110 of 150 in Health CareTop 73% of 150This company $655.4M Sector average $19.6B
▼
-96.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +5.8%, indicating consistent growth.
- In FY2025, revenue increased 8.3% year-over-year.
- Ranks #110 out of 150 companies in the Health Care sector.
- Lowest revenue in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $655.4M | +8.3% |
| FY2024 | $605.2M | +18.8% |
| FY2023 | $509.3M | -5.3% |
| FY2022 | $537.8M | +0.5% |
| FY2021 | $535.0M | +8.2% |
| FY2020 | $494.4M | +40.7% |
| FY2019 | $351.3M | +41.6% |
| FY2018 | $248.1M | +40.1% |
| FY2017 | $177.0M | +113.6% |
| FY2016 | $82.9M | +150.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026